Crossmark

Expanding indication of padeliporfin (WST11) vascular-targeted photodynamic therapy: Results of prostate cancer Latin-American multicenter study

Crossref DOI link: https://doi.org/10.1016/j.acuroe.2018.10.001

Published Print: 2018-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rodriguez-Rivera, J.A.

Rodriguez-Lay, R.

Zegarra-Montes, L.

Benzaghou, F.

Gaillac, B.

Azzouzi, A.R.

Reis, L.O.

Palma, P.
License Information

Text and Data Mining valid from 2018-12-01
More Information

This article is maintained by: Elsevier

Article Title: Expanding indication of padeliporfin (WST11) vascular-targeted photodynamic therapy: Results of prostate cancer Latin-American multicenter study

Journal Title: Actas Urológicas Españolas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuroe.2018.10.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.acuro.2018.02.009

Content Type: article

Copyright: © 2018 AEU. Published by Elsevier España, S.L.U. All rights reserved.